Cite

HARVARD Citation

    Bird, P. et al. (2019). Tofacitinib 5 mg Twice Daily in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs. Journal of clinical rheumatology. 25 (3), p. . [Online]. 
  
Back to record